国产成人嫩模一区二区|超级黄色网页|兔子先生tz|麻豆文化传媒网站官网污|在线播放欧美日韩精品|爱豆影视传媒免费下载|蜜桃影像传媒av剧情|麻豆文化传媒APP最新iOS|陈可心倩女幽魂爱豆传媒|91国视频产,国产传媒播放,想看三级片,网红吃瓜黑料爆料网反差

 
師資隊伍
鄭俊克
  作者:  2018-12-31

基本信息 >>>


                          

鄭俊克

血液干細胞代謝調(diào)控和免疫靶向組

電話:021-63846590-776915

郵箱:[email protected]


研究方向與進展>>>

鄭俊克課題組近幾年的研究揭示了骨髓微環(huán)境中造血干細胞代謝學特性及其與干性維持間的重要關系,特別是造血干細胞獨特的糖/氨基酸等代謝方式及其調(diào)控網(wǎng)絡,;同時闡明了微環(huán)境重要成分Angptls/APOE及其免疫抑制性受體LILRBs/JAM3等在體內(nèi)外維持造血干細胞干性的分子機制,以及在疾病狀態(tài)下白血病干細胞干性維持中的調(diào)控規(guī)律和潛在免疫治療新靶點等,。這些研究為發(fā)展造血干細胞體外擴增新技術及其臨床應用,,尋找靶向白血病干細胞的特異免疫治療靶點以更有效地治療白血病,提供了有力的條件,。

目前本團隊以造血干細胞/白血病干細胞代謝平臺為支持,,結(jié)合動物模型、代謝組學,、代謝感受器,、骨髓微環(huán)境成像和免疫治療(抗體和CAR-T)等相關前沿技術,聚焦于三個主要研究方向:1)造血干細胞和白血病干細胞糖,、氨基酸等內(nèi)在代謝調(diào)控規(guī)律,;2)骨髓微環(huán)境組分調(diào)控造血干細胞穩(wěn)態(tài)和惡變規(guī)律;3)白血病免疫治療機制探討和策略開發(fā),。

研究組長介紹 >>>

鄭俊克,,上海交通大學醫(yī)學院,研究員,,國家杰青項目入選者,。2007年畢業(yè)于上海交通大學醫(yī)學院,;2007-2012年在美國西南醫(yī)學中心從事博士后工作;20126月起受聘于上海交通大學醫(yī)學院細胞分化和凋亡教育部重點實驗室,。主要從事造血干細胞干性維持的機制及其惡性轉(zhuǎn)化為白血病干細胞的規(guī)律研究,。近年來,圍繞血液干細胞代謝和微環(huán)境成分-免疫抑制性受體介導的信號通路在干性維持和免疫靶向中的作用和機制方面,,取得系列重要發(fā)現(xiàn),,并以通訊/共同通訊作者在NatureCell Metabolism(封面文章),、JCI,、BloodLeukemia,、EMBO J等著名雜志上發(fā)表論文13余篇,,目前累計發(fā)表論文50篇,他引1300余次,。所獲資助項目還包括基金委重點項目,、優(yōu)青、面上項目,、上海市優(yōu)秀青年學術帶頭人,、曙光計劃以及浦江人才計劃等。擔任中國生理學會血液專業(yè)委員會委員,、中國病理生理學會青年工作委員會秘書長,、中國細胞生物學學會細胞代謝分會委員等學術職務。獲上海市第十五屆銀蛇獎,、上海市五四青年獎章和吳孟超醫(yī)學青年基金獎等,。

科研項目 >>>

  1. 國家基金委,重點項目,,生理和應激條件下造血干細胞糖代謝異質(zhì)性特征和分子基礎(32030030),,2021.01-2025.12295萬,,在研,,主持

  2. 國家基金委,杰出青年科學基金(81825001),,2019.1-2023.12,,350萬,在研,,主持

  3. 上海市科委,,骨髓代謝性酸環(huán)境調(diào)控白血病干細胞干性維持機制,上海市優(yōu)秀青年學術帶頭人(19XD1422100),2019.05-2022.04, 40萬,,在研,,主持

  4. 科技部干細胞及轉(zhuǎn)化研究重點專項,異染色質(zhì)與端粒調(diào)控干細胞多能性的機制(2018YFA0107000),,2018.1-2022.12,,176萬,在研,,骨干

  5. 科技部發(fā)育和代謝重點專項,,跨器官通訊調(diào)控應激狀態(tài)下骨髓HSC活化和遷徙的作用和機理(2019YFA0801800),2019.12-2024.12,,456萬,,在研,子課題負責人

  6. 國家基金委,,創(chuàng)新研究群體項目(81721004),,2018.1-2023.12100萬,,在研,,骨干

  7. 國家自然科學基金面上項目,骨髓微環(huán)境中血管生成素樣蛋白2對造血干細胞干性維持的作用和意義(81570093),,2016.01-2019.12,,60萬,結(jié)題,,主持

  8. 國家自然科學基金優(yōu)秀青年科學基金,,造血干細胞和白血病干細胞生物學(81422001),2015.01-2017.12,,100萬,,結(jié)題,主持

  9. 科技部重大科學研究計劃,,誘導性前腦神經(jīng)祖細胞體內(nèi)微環(huán)境的組分解析、條件優(yōu)化和功能模擬(2014CB965000),,2014.01-2018.08,,65萬,結(jié)題,,骨干,,參與

  10. 國家自然科學基金面上項目,B7-H1等表面免疫分子在白血病干細胞多能性維持中的作用和機制(81370654),,2014.01-2017.12,,70萬,結(jié)題,主持

  11. 上海市教委曙光計劃,,NADH調(diào)控在急性髓系白血病干細胞多能性維持中的作用(13G20),,2014.09-2016.0915萬,,結(jié)題,,主持

  12. 上海市科委浦江人才計劃(13PJ1405600),急性粒細胞性白血病干細胞的代謝調(diào)控,,2013.09-2015.08,,20萬,結(jié)題,,主持


論文與專著 >>>

  1. H Dan#, Sun G#, Hao X#, He X# , Zheng Z, Chen C, Yu Z, Xie L, Ma S, Liu L, Zhou B O, Chen H*, Zheng J*, Cheng T*. ANGPTL2-containing small extracellular vesicles from vascular endothelial cells accelerate leukemia progression. J Clin Invest ,2020, in press (*,co-corresponding author)

  2. Gu H#, Chen C#, Hao X#, Su N#, Huang D, Zou Y, Lin S, Chen X, Zheng D, Liu L, Yu Z, Xie L, Zhang Y, He X, Lai Xi, Zhang X, Chen GQ, Zhao Y, Yang Y, Loscalzo J, Zheng J, MDH1-mediated malate-aspartate NADH shuttle maintains the activities of fetal liver hematopoietic stem cells, Blood, 136(5):553-571,2020

  3. Hao X, Gu H, Chen C, Huang D, Zhao Y, Xie L, ZouY,  Shu H, Zhang Y, He X, Lai X, Zhang X, Zhou B, Zhang CC, Chen GQ, Yu Z, Yang Y, Zheng J. Metabolic imaging reveals a unique preference of symmetric cell division and homing of leukemia-initiating cells in an endosteal niche. Cell Metab., 29(4):950-965, 2019 (封面文章)

  4. Huang D, Chen C, Hao X, Gu H, Xie L, Yu Z, Zheng J. Metabolic Regulations in Hematopoietic Stem Cells. Adv Exp Med Biol.,1143:59-74, 2019

  5. Zhang LS, Kang X, Lu J, Zhang Y, Wu X, Wu G, Zheng J, Tuladhar R, Shi H, Wang Q, Morlock L, Yao H, Huang LJ, Maire P, Kim J, Williams N, Xu J, Chen C, Zhang CC, Lum L.Installation of a cancer promoting WNT/SIX1 signaling axis by the oncofusion protein MLL-AF9. EBioMedicine. 39:145-158, 2019

  6. Deng M, Gui X, Kim J, Xie L, Chen W, Li Z, He L, Chen Y, Chen H, Luo W, Lu Z, Xie J, Churchill H, Xu Y, Zhou Z, Wu G, Yu C, John S, Hirayasu K, Nguyen N, Liu X, Huang F, LLi L, HDeng H, Tang H, Sadek A, Zhang L, Huang T, Zou Y, Chen B, Zhu H, Arase H, Xia N, Jiang Y, Collins R, You M, Homsi J, Unni N, Lewis C, Chen GQ, YX, X. Liao X, An Z, Zheng J, Zhang N, and Zhang CC. LILRB4 signaling in leukemia cells mediates T cell suppression and tumor infiltration. Nature, 562(7728):605-609, 2018 (*,co-corresponding author)

  7. Peng Y, Yu H, Hao X, Dong W, Yin X, Lin M, Zheng J*, Zhou B*. Luteinizing hormone signaling restricts hematopoietic stem cell expansion during puberty. EMBO J., e98984, 2018(*,co-corresponding author)

  8. Liu X, Zhang F, Zhang Y, Li X, Chen C, Zhou M, Yu Z, Zhao Y, Hao X, Tang B, Zhu L, Liu G, Xie L, Gu H, Shao H, Xia F, Yin C, Tao M, Xie J, Zhang CC, Yang Y, Sun H, Chen GQ, Zheng J. PPM1K regulates hematopoiesis and leukemogenesis through CDC20-mediated ubiquitination of MEIS1 and p21. Cell Rep, 23(5):1461-1475, 2018

  9. Zhang Y, Xia F, Liu X, Yu Z, Xie L, Liu L, Chen C, Jiang H, Hao X, He X, Zhang F, Gu H, Zhu J, Bai H, Zhang CC, Chen GQ, Zheng J. JAM3 maintains leukemia-initiating cell self-renewal through LRP5/AKT/β-catenin/CCND1 signaling. J Clin Invest., 128(5):1737-1751, 2018

  10. Xia F, Zhang Y, Xie L, Jiang H, Zeng H, Chen C, Liu L, He X, Hao X, Fang X, Liu X, Zhang F, Gu H, Wan J, Chen Y, Zhang CC, Chen GQ, Lu Y, Yu Z, Zheng J. B7-H4 enhances the differentiation of murine leukemia-initiating cells via the PTEN/AKT/RCOR2/RUNX1 pathways. Leukemia, 31:2260–2264, 2017

  11. Zhang F, Liu X, Chen C, Zhu J, Yu Z, Xie J, Xie L, Bai H, Zhang Ya, Fang X, Gu H, Wang C, Weng W, Zhang CC, Chen GQ, Liang A, Zheng J. CD244 maintains the proliferation ability of leukemia initiating cells through SHP-2/p27kip1 signaling. Haematologica, 102(4):707-718, 2017

  12. Dai J, Lu Y, Wang C, Chen X, Fan X, Gu H, Wu X, Wang K, Gartner TK, Zheng J, Chen G, Wang X, Liu J. Vps33b regulates Vwf-positive vesicular trafficking in megakaryocytes. J Pathol. J Pathol., 240(1):108-19, 2016

  13. Fang X, Chen C, Xia F, Yu Z, Zhang Y, Zhang F, Gu H, Wan J, Zhang X, Weng W, Zhang CC, Chen G, Liang A, Xie L, Zheng J. CD274 promotes cell cycle entry of leukemia-initiating cells through JNK/Cyclin D2 signaling. J Hemato & Oncol., 9:124, 2016

  14. Gu H, Chen C, Hao X, Wang C, Zhang X, Li Z, Shao H, Zeng H, Yu Z, Xie L, Xia F, Zhang F, Liu X, Zhang Y, Jiang H, Zhu J, Wan J, Wang C, Weng W, Xie J, Tao M, Zhang CC, Liu J, Chen GQ, Zheng J. Sorting protein VPS33B regulates exosomal autocrine signaling to mediate hematopoiesis and leukemogenesis. J Clin Invest., 126(12): 4537-4553, 2016

  15. Xia F, Wang N, Han B, Li Q, Chen Y, Zhu C, Chen Y, Pu X, Cang Z, Zhu C, Lu M, Meng Y, Guo H, Chen C, Lin D, Zheng J, Kuang L, Tuc W, Li B, Hu L, Shen Z, Lu Y. Hypothalamic-Pituitary-Gonadal Axis in Aging Men and Women: Increasing Total Testosterone in Aging Men. Neuroendocrinology, 104(3):291-301, 2017

  16. Zhang F, Zheng J*, Kang X, Deng M, Lu Z, Kim J, Zhang CC. Inhibitory leukocyte immunoglobulin-like receptors in cancer development. Sci China Life Sci, 58(12): 1216-1225, 2015 (*,co-corresponding author)

  17. Kocabas F, Xie L, Xie J, Yu Z, DeBerardinis R J, Kimura W, Thet S, Elshamy A F, Muralidhar S, Liu X, Chen C, Sadek H A , Zhang CC and Zheng J. Hypoxic Metabolism in Human Hematopoietic Stem Cells. Cell Biosci, 5:39, 2015

  18. Shen J, Zheng J, Saxena R, Zhang CC, Tang L. Novel source of human hematopoietic stem cells from peritoneal dialysis effluents. Stem Cell Res, 15(2): 299-304, 2015

  19. Fan X, Shi P, Dai J, Lu Y, Chen X, Liu X, Zhang K, Wu X, Sun Y, Wang K, Zhu L, Zhang CC, Zhang J, Chen GQ, Zheng J*, Liu J. Paired immunoglobin-like receptor B regulates platelet activation. Blood, 124(15):2421-2430 , 2014 (*,co-corresponding author)

  20. Deng M, Lu Z, Zheng J*, Wan X, Chen X, Hirayasu K, Sun H, Lam Y, Chen L, Wang Q, Song C, Huang N, Gao GF, Jiang Y, Arase H, Zhang CC. A motif in LILRB2 critical for Angptl2 binding and activation. Blood, 124(6):924-35, 2014 (*,co-corresponding author)

  21. Zheng J, Lu Z, Kocabas F, Böttcher RT, Costell M, Kang X, Liu X, Deberardinis RJ, Wang Q, Chen G, Sadek H, Zhang CC. Profilin 1 is essential for retention and metabolism of mouse hematopoietic stem cells in bone marrow. Blood, 13;123(7):992-1001,2014

  22. Wang Q, Zhou Z, Zheng Y, Zheng J, Zhang CC. Relationship Between the Structural Specialties and Morphologies Based on a Group of Luminescent Imidazole Derivatives with Sensing Properties. Sci Adv Mater, 6(6): 1133-1139, 2014

  23. Chen X, Zheng J, Zou Y, Song C, Hu X, Zhang CC. IGF binding protein 2 is a cell-autonomous factor supporting survival and migration of acute leukemia cells. J Hematol Oncol., 8;6(1):72, 2013

  24. Zheng J, Umikawa M, Cui C, Li J, Chen X, Zhang C, Huynh H, Kang X, Silvany R, Wan X, Ye J, Cantó AP, Chen SH, Wang HY, Ward ES, Zhang CC. Immune inhibitory receptors bind to angiopoietin-like proteins and support the stemness of hematopoietic and leukemia stem cells. Nature, 485(7400):656-660, 2012

  25. Kocabas F#, Zheng J#, Thet S, Copeland NG, Jenkins NA, DeBerardinis RJ, Zhang C, Sadek HA. Meis1 regulates the metabolic phenotype and oxidant defense of hematopoietic stem cells. Blood, 13(25):4963-4972, 2012 (#, co-first author)

  26. Zheng J, Umikawa M, Zhang S, Huynh H, Silvany R, Chen BP, Chen L, Zhang CC. Ex vivo expanded hematopoietic stem cells overcome the MHC barrier in allogeneic transplantation. Cell Stem Cell, 9(2):119-130, 2011

  27. Zheng J, Huynh H, Umikawa M, Silvany R, Zhang CC. Angiopoietin-like protein 3 supports the activity of hematopoietic stem cells in the bone marrow niche. Blood, 117(2):470-479, 2011

  28. Zheng J, Song C, Zhang CC. A new chapter: hematopoietic stem cells are direct players in immunity. Cell Biosci., 1: 33, 2011

  29. Zhang S, Yajima H, Huynh H, Zheng J, Callen E, Chen HT, Wong N, Bunting S, Lin YF, Li M, Lee KJ, Story M, Gapud E, Sleckman BP, Nussenzweig A, Zhang CC, Chen DJ, Chen BP. Congenital bone marrow failure in DNA-PKcs mutant mice associated with deficiencies in DNA repair. J.Cell.Biol., 193(3):295–305, 2011

  30. Huynh H#, Zheng J#, Umikawa M, Silvany R, Xie XJ, Wu CJ, Holzenberger M, Wang Q, Zhang CC. Components of the hematopoietic compartment in tumor stroma and tumor-bearing mice. PLoS ONE, 6(3): e18054, 2011 (#, co-first author)

  31. Huynh H, Zheng J, Umikawa M, Zhang C, Silvany R, Iizuka S, Holzenberger M, Zhang W, Zhang CC. IGF binding protein 2 supports the survival and cycling of hematopoietic stem cells. Blood, 118(12):3236-3243, 2011

  32. Simsek T#, Kocabas F#, Zheng J#, Deberardinis RJ, Mahmoud AI, Olson EN, Schneider JW, Zhang CC, Sadek HA. The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche. Cell Stem Cell, 7(3):380-390, 2010 (#, co-first author)

  33. Lou Z, Zhang CC, Tirado CA, Slone T, Zheng J, Zaremba CM, Oliver D, Chen W. Infantile mixed phenotype acute leukemia (bilineal and biphenotypic) with t(10;11)(p12;q23);MLL-MLLT10. Leuk Res., 34(8): 1107-1109, 2010

  34. Huynh H, Iizuka S, Kaba M, Kirak O, Zheng J, Lodish HF, Zhang CC. Insulin-like growth factor-binding protein 2 secreted by a tumorigenic cell line supports ex vivo expansion of mouse hematopoietic stem cells. Stem Cells, 26(6): 1628-1635, 2008

  35. Zheng J, Xia X, Ding H, Yan A, Hu S, Gong X, Zong S, Zhang Y, Sheng HZ. Erasure of the paternal transcription program during spermiogenesis: the first step in the reprogramming of sperm chromatin for zygotic development. Dev Dyn., 237(5): 1463-1476, 2008

  36. Yang Y#, Zheng J#, Zhou X, Yang Z, Tan Y, Liu A, Gao X, Chang Z, Sheng HZ. Potential treatment of liver related disorders with in vitro expanded human liver precursors. Differentiation, 75(10): 928-938, 2007 (#, co-first author)

  37. Sun F, Fang H, Li R, Gao T, Zheng J, Chen X, Ying W, Sheng HZ. Nuclear reprogramming: the zygotic transcription program is established through an "erase-and-rebuild" strategy. Cell Res., 17(2): 117-134, 2007

  38. Gao T#, Zheng J#, Xing F#, Fang H, Sun F, Yan A, Gong X, Ding H, Tang F, Sheng HZ. Nuclear reprogramming: the strategy used in normal development is also used in somatic cell nuclear transfer and parthenogenesis. Cell Res., 17(2): 135-150, 2007(#, co-first author)

  39. Chen B#, Shi J#, Zheng J#, Chen Y, Wang K, Yang Q, Chen X, Yang Z, Zhou X, Zhu Y, Chu J, Liu A, Sheng HZ. Differentiation of liver cells from human primordial germ cell-derived progenitors. Differentiation, 75(5): 350-359, 2007 (#, co-first author)


出版著作

  1. Huynh      H, Kaba M, Rudra S, Zheng J, Wu      CJ, Lodish HF, Zhang CC. IGFBP2 Supports ex vivo Expansion of      Hematopoietic Stem Cells, Book Title: IGFs: Local Repair and Survival      Factors Throughout Life Span. Springer-Verlag      Berlin Heidelberg, 2010

  2. Kocabas      F, Zheng J, Zhang CC and Sadek      HA. Metabolic Characterization of Hematopoietic Stem Cells. Hematopoietic Stem Cell Protocols.      Springer. 2014

  3. Huang      D, Chen C, Zheng J. Leukemia Stem Cells in Hematologic      Malignancies: metabolic regulations in hematopoietic stem cells, Springer,      2019, ISBN 978-1-4939-1132-5.

  4. Zhang Y, Zheng J. Regulation      of Cancer Immune Checkpoints: Functions      of Immune Checkpoint, Springer, 2020, ISBN 978-981-15-3265-8.


專利>>>


  1. Chen SH, Zhang CC, Zheng J, Masato U, Kang X. 2012. Compositions and methods for modulating pro-inflammatory immune response. U.S. patent application 61/653,337

  2. Zhang CC, Liu Y, Zheng J, Deng M, Chen C, Liu W. 2014. Novel compound supports hematopoietic stem cells and red blood cells. U.S. patent application 62/003,969

  3. Zhang CC, Liu Y, Zheng J, Deng M, Chen C, Liu W. 2015. Novel compound supports hematopoietic stem cells and red blood cells. Canada, patent application 2,950,269

  4. Zhang CC, Liu Y, Zheng J, Deng M, Chen C, Liu W. 2014. Novel compound supports hematopoietic stem cells and red blood cells.15798855.1-1453 PCT/US201503352

  5. Bernstein ID, Zhang CC, Zheng J, Deng M, Lu Z. 2014. LILRB2 and Notch-mediated expansion of hematopoietic precursor cells. U.S. patent application 62/005,746

  6. Zhang CC, Deng M, An Z, Xiong W, Zhang N, Zheng J, Anti-LILRB antibodies and their use in detecting and treating cancer. 2015 U.S. patent application 62/129,572

團隊介紹 >>>


 目前團隊包括副研,、助研、技術員,、博士后,、博士和碩士研究生等共有15人,課題組積極營造團結(jié)互助,、銳意進取,、努力攻艱的實驗室氛圍,培養(yǎng)了多名優(yōu)秀青年科研人才,,大大提升了團隊科研水平,。副研究員入選基礎醫(yī)學院優(yōu)秀青年教師計劃,也獲得國家自然科學基金面上項目和上海市科委自然科學基金面上項目資助,;助理研究員獲得國家自然科學基金青年項目和上海市科委自然科學基金面上項目資助,;所指導的4名博士后中(3名已出站),1名獲得國家自然科學基金青年項目,,1名獲國家博士后創(chuàng)新人才計劃資助,,1名獲中國博士后科學基金面上項目(一等)資助;課題組精心為所有的指導研究生制定個性化培養(yǎng)計劃,,培養(yǎng)出了多名優(yōu)秀學生,。課題組已培養(yǎng)畢業(yè)碩士生1名和博士生9名(其中3名和4名分別在美國和中國從事博士后工作,2名博士后獲國家自然科學基金青年項目,,1名博士獲國家自然科學基金面上項目并晉升為副研究員),;3名學生獲得國家獎學金,1名獲上海市優(yōu)秀畢業(yè)生,,1名獲中國科學院大學優(yōu)秀畢業(yè)生和院長優(yōu)秀獎,,2名獲上海交通大學優(yōu)秀博士論文;目前,,指導在讀博士生6名及碩士生1名,;指導的學生多次在國內(nèi)外學術會議口頭報告或墻報評比中獲獎,。